Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Strategic Asset Allocation Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Strategic Asset Allocation Index of 9.0% as of September 2023. Strategic assets (PP&E of CN¥576.74 Million plus long-term investments of CN¥-) total CN¥576.74 Million, measured against net assets of CN¥6.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Wuhan Easy Diagnosis Biomedicine Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Strategic Asset Allocation Index (2015–2022)
This chart shows how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of September 2023, the index stands at 9.0%, representing strategic assets of CN¥576.74 Million against net assets of CN¥6.39 Billion CNY.
Annual Strategic Asset Allocation Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Wuhan Easy Diagnosis Biomedicine Co Ltd stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.8% | CN¥525.97 Million | CN¥525.97 Million | CN¥- | CN¥6.77 Billion | ▼ -0.8 pp |
| 2021 | 8.5% | CN¥243.47 Million | CN¥243.47 Million | CN¥- | CN¥2.85 Billion | ▼ -2.5 pp |
| 2020 | 11.1% | CN¥123.26 Million | CN¥123.26 Million | CN¥- | CN¥1.11 Billion | ▼ -4.7 pp |
| 2019 | 15.8% | CN¥97.26 Million | CN¥97.26 Million | CN¥- | CN¥615.62 Million | ▲ +0.6 pp |
| 2018 | 15.2% | CN¥90.02 Million | CN¥90.02 Million | CN¥- | CN¥592.59 Million | ▼ -13.5 pp |
| 2017 | 28.7% | CN¥69.66 Million | CN¥69.66 Million | CN¥- | CN¥242.93 Million | ▲ +1.8 pp |
| 2016 | 26.9% | CN¥47.12 Million | CN¥47.12 Million | CN¥- | CN¥175.08 Million | ▲ +16.2 pp |
| 2015 | 10.7% | CN¥12.38 Million | CN¥12.38 Million | CN¥- | CN¥115.39 Million | — |